Key facts
- It has raised $4.6M; the latest was Seed Round ($3.4M) in Jun 2025.
- Notable investors include Angels4Women, Barbara Marini, Claudia Benelli, Cristian D'Ippolito, Dario Calogero — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Lionhealth
- ·The full record, as it builds
Funding rounds
No funding rounds for Lionhealth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lionhealth
Manufacturer of specialized nutritional products designed for managing disease-related nutritional needs. The company develops medical food formulations using scientific research and plant-based extracts, adhering to environmental and social governance principles, with products tailored to support patients in maintaining or restoring nutritional balance, enabling clinicians to access targeted dietary services that address specific health conditions and improve patient care outcomes.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Milan, Italy
- Founded
- 2022
- Employees
- 8
- Website
- lionhealth.tech/
- Ownership
- Privately Held (backing)
Lionhealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lionhealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lionhealth in its N-PORT filings yet. We sweep new filings monthly.